Suchergebnisse - "Suenaga, Mitsukuni"

PubPharm (204)

1

Clinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer

enthalten in: Anaerobe | 2023

von Matsumiya, Y. | Suenaga, M. | Ishikawa, T. | +12

2

The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of Head and Neck

enthalten in: Medicina (Kaunas, Lithuania) | 2023

von Naito, T. | Noji, R. | Kugimoto, T. | +6

3

Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Kano, Y. | Suenaga, M. | Uetake, H.

4

Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer

enthalten in: Cancers | 2022

von Noji, R. | Tohyama, K. | Kugimoto, T. | +18

5

Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal MET Amplification from Aneuploidy in Diverse Advanced Cancers

enthalten in: Current oncology (Toronto, Ont.) | 2021

von Kumaki, Y. | Olsen, S. | Suenaga, M. | +3

6

Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Kobayashi, K. | Sugiyama, E. | Shinozaki, E. | +22

7

Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer

enthalten in: The pharmacogenomics journal | 2021

von Suenaga, M. | Schirripa, M. | Cao, S. | +12

8

Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients

enthalten in: Cancer genomics & proteomics | 2021

von Suenaga, M. | Zhang, W. | Mashima, T. | +8

9

Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Kobayashi, K. | Sugiyama, E. | Shinozaki, E. | +22

10

Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Kobayashi, K. | Sugiyama, E. | Shinozaki, E. | +22

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]